The medtech industry is continuing its massive 2021 boom, with the past week marking yet another record in the markets. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 27) at 121.05 points, representing a 1.2% rise from the 119.63-point mark set a week before. […]
MassDevice Earnings Roundup
Medtronic CEO Geoff Martha touts progress on renal denervation and Hugo robotics
Medtronic (NYSE: MDT) is boosting its research and development spending in fiscal year 2022 by more than 10%, which CEO Geoff Martha described as the largest dollar increase ever for the Fridley, Minn.-based medtech giant. “The investments we’re making in our pipeline will play a key role in accelerating our top-line growth, and we’re at […]
Medtronic beats The Street on 23% sales growth in Q1
Medtronic (NYSE:MDT) posted first-quarter results today that beat the overall consensus on Wall Street and updated its full-year guidance. The Fridley, Minn.–based company reported profits of $769 million, or 56¢ per share, on sales of $7.98 billion for the three months ended July 30, for a bottom-line gain of 56.6% on sales growth of 22.74% […]
MedTech 100 roundup: On the rise again
After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior. […]
Alcon reports 74% sales growth in Q2, raises 2021 guidance
Alcon (NYSE:ALC) this week posted second-quarter results that beat the overall consensus on Wall Street and raised its full-year guidance. The Geneva-based eye care company reported profits of $151 million, or 31¢ per share, on sales of $2.1 billion for the three months ended June 30, for a sales growth of 74.79% compared with Q2 2020. […]
MedTech 100 roundup: Hot streak comes to slight halt
After several weeks of high-level performance, the medtech industry saw its first dip in a while over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 13) at 117.92 points, marking a –1.2% dip from the 119.41-point tally a week prior […]
Accuray beats The Street in Q4
Accuray (NSDQ:ARAY) shares dipped this morning despite fourth-quarter results that beat the consensus forecast. The Sunnyvale, Calif.-based radiation oncology company posted losses of -$11.1 million, or -12¢ per share, on sales of $110.9 million for the three months ended June 30, 2021, for a massive bottom-line slide from losses of $152,000 this time last year […]
Avinger reports Street-beating revenues in Q2
Avinger (NSDQ:AVGR) shares stood still this morning on second-quarter sales numbers that topped the consensus forecast. The Redwood City, Calif.-based image-guided catheter developer posted losses of -$3.5 million on sales of $2.8 million for the three months ended June 30, 2021, for a 43.1% bottom-line gain on sales growth of 9.5%. Earnings per share came […]
Bioventus posts Street-beating Q2, raises guidance
Bioventus (NSDQ:BVS) shares ticked up before hours on second-quarter results that beat the consensus forecast. The Durham, N.C.-based ortho tech company posted losses of -$10.8 million, or -10¢ per share, on sales of $109.8 million for the three months ended July 3, 2021, for a -80.3% bottom-line slide on sales growth of 89.3%. Adjusted to […]
Sientra misses Wall Street estimates in Q2
Sientra (NSDQ:SIEN) posted second-quarter results this week that missed the earnings and revenue estimates on Wall Street. The Santa Barbara, Calif.-based medical aesthetics company reported losses of -$20.1 million, or -35¢ per share, on sales of $20.1 million for the three months ended June 30 for a sales growth of 115.95% compared with Q2 2020. Sientra’s […]
InspireMD sales up 231% in mixed-bag Q2 results
InspireMD (NYSE:NSPR) posted second-quarter results this week that beat the earnings consensus on Wall Street but missed revenue estimates. The Tel Aviv, Israel-based carotid stenting company reported losses of $3.5 million, or -46¢ per share, on sales of $1.03 million for the three months ended June 30, for a sales growth of 231.63% compared with Q2 […]
